Transcript Slide 1

Funding Update: Current Situation and
Future Prospects
September 18, 2012
Andrea Gay, UNF
1
MR Initiative Annual Expenditure,
2001-2012
180
160
Total expenditure 2001-2012 = $935 million
$ US Million
140
120
100
80
60
40
20
0
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Donations
* Excluding country contributions
Rollover from 2009
2
Measles & Rubella Initiative Annual Donations
2001-2012 and Financial Resource Requirements,
Projections,
Funding Gap 2012-2015*
350
300
$ US Million
250
94
200
59
11
150
36
38
44
100
50
0
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Funding gap (includes PSC)
Carryover
Funds Projected or Pledged (includes GAVI funding for M + MR SIAs)
Donations
* Excludes all country contributions and direct social mobilization funding from partners
3
Measles & Rubella Initiative Financial Resource
Requirements, Projections, Funding Gap 2013-2015
47
400
Total Funding Gap 2013-2015: US $96 million
350
$ US Million
300
32
18
31
250
200
150
100
50
0
2013
2014
Anticipated Country Contributions
Donor Funds Projected/Pledged/Received
2015
Anticipated GAVI Contribution (Rubella)
Funding Gap (includes PSC)
4
Resource Requirements by Major Category of Activity,
2013-2015
400
350
Total Cost 2013-2015: US $739 million
$US Million
300
250
200
150
100
50
0
2013
2014
2015
Measles SIAs
Measles Rubella SIAs
Technical Assistance
Outbreak Response
Surveillance / Lab
Coverage Surveys
Research
Communication
5
MR Initiative Donors, 2001-2012
Bi-laterals
CIDA
CDC
JICA
Norway
DFID
Civil Society
ARC*
LDS
Lions
UN
UNICEF
UNF*
Foundations
Gates
Private Sector
BD
Merck
Vodaphone
Other
GAVI/IFFIm
6
* Includes ARC/UNF and other partners
Where is the Measles & Rubella Initiative Headed?
• 2012 measles goals: AFRO (pre-elimination) and WPRO (elimination)
• 2013 potential SEARO elimination goal set, begin MR introduction
campaigns with GAVI support
• 2015 GIVS (95% mortality reduction) and MDG 4 goals; measles goal
in EMRO and EURO (elimination); rubella goal in EURO (elimination)
• 2020 goal in AFRO (elimination)
• Expand rubella introduction where appropriate; set goals
Critical Elements for Success
•
•
•
•
Political leadership
Timely funding (donor and national governments)
Adequate time for planning and social mobilization
Well performing surveillance
7
Measles and rubella elimination goals
by WHO Region, March 2012
2015
2015
2000
2010
2015
2020
Pre-elim.
(98%)
2012
2012
SEAR: 95% Measles
Mortality Reduction
by 2015
Elimination 2020?
Americas, Europe, E. Mediterranean, W. Pacific, Africa have measles elimination goals
Americas and Europe have rubella elimination goals
8
Considerations for Reorganizing Aspects of
MR Initiative Operations
•
•
•
•
•
•
•
•
•
•
Measles eradication investment case (EIC): research, costing options
Strategic funding for regional elimination goals
Strategic support for non-GAVI eligible countries
Increased surveillance costs (including lab, coverage surveys)
Increased communications costs
Increased training costs for SIAs
Type of MR Initiative involvement (ex: T.A.) in GAVI funded MR intro SIAs
or GAVI funded measles SIAs in 6 large countries
Outbreak response fund
Routine immunization
– Scale up of MCV1
– Increase MCV2 introduction
Rubella & CRS (MR)
– Follow-up campaigns
9